Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble il-4 receptor

International Archives of Allergy and Immunology

Volumn 109, Issue 2, 1996, Pages 167-176

  Renz, Harald ^a   Bradley, Katherine ^a   Enssle, Karlheinz ^b   Loader, Joan E ^a   Larsen, Gary L ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b Behringwerke AG   (Germany)

Author keywords

Airway hyperresponsiveness; Hypersensitivity; IL 4 receptor; Immediate; Soluble

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 4 RECEPTOR; MONOCLONAL ANTIBODY; OVALBUMIN;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ELECTRIC FIELD; FEMALE; IMMEDIATE TYPE HYPERSENSITIVITY; MOUSE; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SKIN ALLERGY; TRACHEA MUSCLE; ULTRASOUND;

EID: 0030040387     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237216     Document Type: Article

References (42)

1. Gerondakis S: Structure and expression of murine germline immunoglobulin heavy chain transcripts induced by interleukin 4. Proc Natl Acad Sei USA 1990:87:1581-1585.
2. Gauchat JF, Lebman DA, Coffman RI, Dascan H, de Vries JE: Structure and expression of germline r transcripts in human B cells induced by interleukin 4 to switch to IgE production, J Exp Med 1990; 172:463-473.
3. Stavnczer J, Radcliffc G, Lin Y-C, Nietupski J, Berggren L, Sitia R, Severinson F,: Immunoglobulin heavy-chain switching may be directed by prior induction of transcripts from constant-re-gion genes, Proc Natl Acad Sei USA 1988:85: 7704-7708.
4. Rothman P, Lutzker S, Cook W, Coffman R, Alt FW: Mitogen plus interleukin-4 induction of Ce transcripts in B-lymphoid cells, J Exp Med 1988:168:2385-2389.
5. Rothman P, Chen Y-Y, Lutzker S, Li SC, Stewart V, Coffman R, Alt F: Structure and expression of germline immunoglobulin heavy-chain e transcripts: Interleukin-4 plus lipopolysacca-ride-directed switching to Cr, Mol Cell Biol 1990; 10:1672-1679.
6. Finkelman FD, Katona IM, Urban JF Jr., Ilolmes J, Ohara J, Tung AS, Sample JVG, Paul WE: Interleukin-4 is required to generate and sustain in vivo IgE responses, J Immunol 1988:141: 2335-2341.
7. Finkelman FD, Katona IM, Urban IF, Jr., Snapper CM, Ohara J, Paul WE: Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine BSF-I, Proc Nall Acad Sei USA 1986:83:9675-9678.
8. Finkelman FD, Urban JF, Jr., Beckmann MP, Holmes JM, Katona IM: Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody, lilt Immunol 1991:3:599-607.
9. Beckmann MP, Gallis B, Banden Bos T, Friend D, Alpert AR, Raunio R, Prickett KS, Baker PE, Par LS: Monoclonal antibodies block murine IL-4 receptor funciton, J Immunol 1990:144:4212-4217.
10. Kühn R, Rajewsky K, Müller W: Generation and analysis of interleukin-4 deficient mice, Science 1991;254:707-710.
11. Gurevitch AW, Heiner DC, Rcisner RM, Galif TA: IgE in atopic dermatitis and other common dermatoses, Arch Dermatol 1973:107:712-715.
12. Öhman S, Johansson SG: Allergen-specific IgE in atopic dermatitis, Acta Derm Vencrcol Stockhl 1974;54:283-290.
13. Church JA, Kleban DG, Bellanti JA: Serum immunoglobulin E concentrations and radioallcr-gosorbent tests in children with atopic dermatitis, PcdiatrRes 1976:10:97-99.
14. Stone SP, Muller SA, Gleich G: IgE levels in atopic dermatitis, J Arch Dermatol 1973:108: 806-811.
15. Stone SP, Gleich GJ, Muller SA: Atopic dermatitis and IgE, Arch Dermatol 1976; 112:1254- 1255.
16. Tang M, Kemp A, Varigos G: IL-4 and intcrfe-ron-gamma production in children with atopic disease, Clin Exp Immunol 1993:92:120-124.
17. Romagnani S, Maggi E, Del Prete GF, Parron-clii P, Macchia D, Tiri A, Ricci M: Role of interleukin 4 and gamma interferon in the regulation of human IgE synthesis: Possible alterations in atopic patients, Int Arch Allergy Appl Immunol 1989:88:111-113.
18. Roussct F, Robert J, Andary M, Bonnin JP, Souillet G, Chrétien I, Brièrc F, Pcnc J, de Vries JE, I: Shifts in interleukin-4 and intcrfcron-y production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis, Allergy Clin Immunol 1991:87:58-69.
19. Jujo K, Ren H, Abe J, Gelfand EW, Leung DYM: Decreased gamma interferon and increased interlcukin-4 production in atopic dermatitis promotes IgE synthesis, Allergy Clin Immunol 1992:90:323-331.
20. van der Heijden FL, Wierenga EA, Bos JD, Kapscnberg ML: Fligh frequency of lL-4-pro-ducing CD4 allergen-specific T lymphocytes in atopic dermatitis lesional skin, J Invest Dermatol 1991;97:389-394.
21. Renz H, Enssle K, Lauffer L, Kurrle R, Gelfand EW: Inhibition of allergen-induced IgE and IgG I production by soluble IL-4 receptor (sIL-4R), lilt Arch Allergy Immunol 1995:106: 46-54.
22. Renz H, Smith HR, Henson JE, Ray BS, Irvin CG, Gelfand EW: Aerosolized antigen exposure without adjuvant causes increased IgE production and airways hyperresponsiveness in the mouse, J Allergy Clin Immunol 1992:89:1127-1138.
23. Saloga J, Renz II, Lack G, Bradley K, Larsen G, Gelfand EW: Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen, J Clin Invest 1993:91:133-140.
24. Larsen GL, Renz FI, Loader JE, Bradley KL, Gelfand EW: Airway response to electrical field stimulation in sensitized inbred mice: Passive transfer of increased responsiveness with peribronchial lymph nodes, J Clin Invest 1992:89: 747-752.
25. Renz H, Saloga J, Bradley KL, Loader JE, Grcenstcin JL, Larsen GL, Gelfand EW: Specific Vp T-cell subsets mediate the immediate hypersensitivity response to ragweed allergen, J Immunol 1994; 151:1907-1917.
26. Ren H, Bradley KL, Marrack P, Gelfand EW: T cells expressing variable elements of T-eell receptor β8 and >2 chain regulate murine IgE production, Proc Natl Acad Sci USA 1992;89: 6438-6442.
27. Ren H, Bradley KL, Larsen GL, McCall C, Gelfand EW: Comparison of the allergenicity of ovalbumin and ovalbumin peptide 323 339. Differential expansion of V3-expressing T-cell populations, J Immunol 1994;151:7206-7213.
28. Ren H, Bradley K, Saloga J, Loader J, Larsen GL, Gelfand EW: T cells expressing specific V[3 elements regulate IgE production and airways responsiveness in vivo, J Exp Med 1993; 177:1175-1180.
29. Maliszcwski CR, Sato TA, Vandcn Bos T, Waugh S, Dower SK, Slack J, Beckmann MP, Grabstein KH: Cytokine receptors and B cell functions, J Immunol 1990;144:3028-3033.
30. Malisewski CR, Morrissey PJ, Fanslow WC, Sato TA, Willis C, Davison B: Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor, Cell Immunol 1992:143: 434-448.
31. Femandez-Botran R, Vitetta ES: A soluble high-affinity, intcrleukin-4-binding protein is present in the biological fluids of mice, Proc Natl Acad Sci U S A 1990;87:4202-4206.
32. Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, Vanden Bos T, Friend D, Al-pert A, Anderson D, Jackson J, Wignall JM, Smith C, Gallis B, Sims JE, Urdal D, Widmer MB, Cosman D, Park LS: The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms, Cell 1989;59:335-348.
33. Sato TA, Widmer MB, Finkclman FD, Madani H, Jacobs CA, Grabstein KU, Malisewski CR: Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo, J Immunol 1993;150:2717-2723.
34. Femandez-Botran R, Vitetta ES: Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins, J Exp Med 1991: 174:673-681.
35. McKenzie ANJ, Culpepper JA, De Waal Male-Fyt R, Briere F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S, De Vries JE, Banchcrcau J, Zurawski G: Interleukin 13. a T-cell-derived cytokine that regulates human monocyte and B-cell function, Proc Natl Acad Sci USA 1993:90:3735-3739.
36. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, De Waal Malefyt R, De Vries JE: Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells, Proc Natl Acad Sei U S A 1993:90:3730-3734.
37. Lack G, Renz II, Saloga J, Bradley KL, Loader J, Leung DYM, Larsen G, Gelfand EW: Nebulized but not parenteral interferon-y decreases IgE production and normalizes airways function in a murine model of allergen sensitization, J Immunol 1994:152:2546-2554.
38. Saloga J, Renz II, Larsen GL, Gelfand EW: Increased airways responsiveness in mice is dependent on local challenge with antigen despite systemic sensitization, Am J Respir Crit Care Med 1994;149:65-70.
39. Valent P, Bcvcc D, Maurer D, Besemer J, DiPa-dova F, Butterfield JH, Speiser W, Majdic O, Lechncr K, Bettelhcim P: Interleukin 4 promotes expression of mast cell ICAM-1 antigen, Proc Natl Acad Sei U S A 1991:88:3339-3342.
40. White MV, Igarashi Y, Emery BE, Lotze MT, Kaliner MA: Effects of in vivo administration of interleukin-2 (IL-2) and IL-4. alone and in combination, on ex vivo human basophil histamine release, Blood 1992;79:1491-1495.
41. Madden KB, Urban JF Jr., Zillener HJ, Schrader JW, Finkclman FD, Katona IM: Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis, J Immunol 1991:147:1387- 1391.
42. Pedersen M, Pcrmin H, Bindslev-Jensen C, Bendtzen K, Nom S: Cytokine-induced histamine release from basophils of AIDS patients, Allergy 1991:46:129-134.